Home » Products » Nimodipine Injection 10mg/50ml | GMP Manufacturer & Supplier | Sinophare
-
- Dosage: Nimodipine 10mg
- Volume: 100 ml
- Packaging: Sterile bottle for injection, 30 bottles in carton
- Shelf Life: 36 months
Package:
Product Description
| Product Name | Nimodipine Injection |
| Specification | 10mg/50mL (0.2mg/mL) |
| Dosage Form | Sterile, Nonpyrogenic Solution for Intravenous Infusion |
| Active Ingredient | Nimodipine |
| Pharmacological Class | Dihydropyridine Calcium Channel Blocker / Cerebrovascular Selective Calcium Antagonist |
| Route of Administration | Intravenous infusion only (via infusion pump). NOT for intramuscular, subcutaneous, or direct intravenous bolus injection. Use non-PVC administration tubing (nimodipine may leach from PVC). |
| Packaging | 50mL sterile glass ampoule or vial (with rubber stopper and aluminum seal) |
| Storage | Store below 25°C, protected from light. Do not freeze. Keep ampoules/vials in outer carton until use. |
| Shelf Life | 36 months (unopened) |
Product Overview
Nimodipine Injection 10mg/50mL is a sterile, nonpyrogenic solution of nimodipine intended for intravenous infusion. Each 50mL ampoule or vial contains 10mg of nimodipine at a concentration of 0.2mg/mL. Nimodipine is a lipophilic dihydropyridine calcium channel blocker with preferential cerebrovascular selectivity. The intravenous formulation is designed for use in patients with aneurysmal subarachnoid hemorrhage (SAH) who are unable to tolerate oral therapy or in whom oral absorption is unreliable, and for the prevention and treatment of ischemic neurological deficits due to cerebral vasospasm following SAH.
